The CDL strategy for the “point-directed assignment” of NMR spectra. (
A) The [
1H-
15N] cross-peak in HSQC will appear only if the second residue in a pair is
15N labeled (second box tagged 1). The [
1H-
15N] cross-peak in the HSQC spectrum and the [
1H-
15N-
13C] cross-peak in the HNCO spectrum will both appear only if the peptide group is double [
13C-
15N]-labeled (third box tagged 2). (
B) Dual
15N/
13C combinatorial selective labeling scheme designed specifically for backbone assignment of KdpD(397-502) (see details in SI Text). (
C) Assignment of
1H-
15N cross-peaks of KdpD(397-502) using a combinatorial scheme of selective
13C,
15N labeling, presented in panel
B. The overlays of [
1H-
15N]-TROSY-HSQC (red contours) and [
1H-
15N] projection of TROSY-HNCO (blue contours) spectra are shown for each sample (I–VI). Absence of a cross-peak (tag “0”), a cross-peak present in TROSY only (tag “1”), and cross-peaks present in both the TROSY and the HNCO spectra (tag “2”) in each combinatorially labeled sample determine the code (sequence of the tags) for every cross-peak A, B, and C in a uniformly labeled sample. The scheme-designed code which is identical with the code determined from the recorded spectra defines a pair of amino acids for the

,

, and

resonances.